Come up with a name for your new list and we'll add to it:
Bionpharma raised a round of funding on December 15, 2015. Investors include
Signet Healthcare Partners.
Bionpharma develops and distributes high quality, affordable generic pharmaceutical products to the US market by building a portfolio through internal development and mutually beneficial partnerships …